Tumour SNPs Associated with Immune-Related Hepatitis in Patients with Melanoma Receiving Immune Checkpoint Inhibitors

Thumbnail Image

Files

Tumour SNPs.pdf (243.64 KB)
Identifiers
URI: https://hdl.handle.net/11268/17154
DOI: 10.3390/biomedicines13102351

Publication date

2025

Authors

Rodríguez Piñas, José María

Advisors

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

SDG

goal-3

Metrics

Google Scholar
2

Research Projects

Organizational Units

Journal Issue

Abstract

Immune checkpoint inhibitors (ICIs) have significantly improved survival rates for patients with metastatic melanoma. However, these treatments can lead to immune-related adverse events (irAEs), including hepatitis. This exploratory study sought to identify tumour single-nucleotide polymorphisms (SNPs) associated with the risk of ICI-induced hepatitis in melanoma patients.

Description

UNESCO Subjects

Cáncer
Patología
Inmunología

Keywords

Bibliographic reference

Rodríguez-Piñas, J. M., Romero-Lorca, A., Gaibar, M., Novillo, A., Rubio, M., Malón, D., Antón-Pascual, B., Camacho, F. I., Cavanagh, M., Luján, D. R., Martín, A. M., Khedaoui, R., Moreno, D., Pinedo, F., Boiza, M., García-Adrián, S., Gómez, P., Marrupe, D., & Fernández-Santander, A. (2025). Tumour snps associated with immune-related hepatitis in patients with melanoma receiving immune checkpoint inhibitors. Biomedicines, 13(10), 2351. https://doi.org/10.3390/biomedicines13102351
Editor's version
https://doi.org/10.3390/biomedicines13102351

Type of document

journal article

Collections

Área de Biomedicina Clásica
Attribution 4.0 International

La licencia de este ítem se describe como Attribution 4.0 International